Eos Biotechnology Inc., of South San Francisco, added Dale Johnson as vice president, preclinical and predictive development.
Evotec OAI AG, of Hamburg, Germany, appointed Dirk Ehlers chief financial officer.
Genencor International Inc., of Palo Alto, Calif., named David Thomassen vice president, business development of health care.
ILEX Oncology Inc., of San Antonio, appointed Jeffrey Buchalter president. Also, it promoted William Mikrut and added Terry Murdock, both as vice president, clinical operations.
Immunomedics Inc., of Morris Plains, N.J., appointed Gerard Gorman vice president and chief financial officer.
Inspire Pharmaceuticals Inc., of Durham, N.C., appointed Lisa LaVange president of biostatistics and data management and Amy Schaberg senior director of clinical research. Also, it promoted Anita Woodring to director of regulatory affairs.
Interleukin Genetics Inc., of Waltham, Mass., named Kenneth Huttner medical director and Marissa Peacock director of clinical operations, both in the department of clinical research and development.
Keryx Biopharmaceuticals Inc., of Cambridge, Mass., appointed Rony Seger chief scientific officer.
Lorantis Ltd., of London, appointed Karl Schaffenburg chief business officer.
Morphotek Inc., of Philadelphia, appointed John Kim, Enrico Petrillo and David Stone to its board.